Cargando…
IL-22 inhibits bleomycin-induced pulmonary fibrosis in association with inhibition of IL-17A in mice
BACKGROUND: Interstitial lung disease, a common extra-articular complication of connective tissue disease, is characterized by progressive and irreversible pulmonary inflammation and fibrosis, which causes significant mortality. IL-22 shows a potential in regulating chronic inflammation and possibly...
Autores principales: | Qu, Ziye, Dou, Wencan, Zhang, Kexin, Duan, Lili, Zhou, Dongmei, Yin, Songlou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789559/ https://www.ncbi.nlm.nih.gov/pubmed/36564791 http://dx.doi.org/10.1186/s13075-022-02977-6 |
Ejemplares similares
-
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
por: Wilson, Mark S., et al.
Publicado: (2010) -
RETRACTED ARTICLE: Qilongtian ameliorate bleomycin-induced pulmonary fibrosis in mice via inhibiting IL-17 signal pathway
por: Zhang, Qiang, et al.
Publicado: (2023) -
Retraction Note: Qilongtian ameliorate bleomycin-induced pulmonary fibrosis in mice via inhibiting IL-17 signal pathway
por: Zhang, Qiang, et al.
Publicado: (2023) -
Interleukin-22 Inhibits Bleomycin-Induced Pulmonary Fibrosis
por: Liang, Minrui, et al.
Publicado: (2013) -
IL-27 alleviates the bleomycin-induced pulmonary fibrosis by regulating the Th17 cell differentiation
por: Dong, Zhaoxing, et al.
Publicado: (2015)